| 发明名称 |
LYMPHOTOXIN BETA RECEPTOR AGENTS IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS |
| 摘要 |
<p>This invention features combination therapies that include a composition that activates lymphotoxin-beta receptor signaling in combination with one or more other chemotherapeutic agents, as well as therapeutic methods and screening methods for identifying agents that in combination with a lymphotoxin-beta receptor agonist agent have a supra-additive effect on tumor inhibition.</p> |
| 申请公布号 |
EP1585547(A4) |
申请公布日期 |
2006.10.25 |
| 申请号 |
EP20030808561 |
申请日期 |
2003.12.22 |
| 申请人 |
BIOGEN IDEC MA INC. |
发明人 |
LEPAGE, DOREEN;GILL, ALAN |
| 分类号 |
A61K;A61K39/395;C07K16/28;(IPC1-7):A61K39/395 |
主分类号 |
A61K |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
